TickerFactsScreenerDevelopers

10x Genomics, Inc. (TXG) — Operating Income

Annual figures by fiscal year, from SEC filings.

2017: -$18.38M2018: -$110.76M2019: -$30.57M2020: -$534.14M2021: -$52.25M2022: -$167.94M2023: -$265.33M2024: -$194.56M2025: -$60.98M-$60.98M
2017Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$60.98M+68.7%
2024-$194.56M+26.7%
2023-$265.33M-58.0%
2022-$167.94M-221.4%
2021-$52.25M+90.2%
2020-$534.14M-1647.1%
2019-$30.57M+72.4%
2018-$110.76M-502.8%
2017-$18.38M—